Asia Pacific Neuroscience Antibodies And Assays Market Size & Outlook
Related Markets
Asia Pacific neuroscience antibodies and assays market highlights
- The Asia Pacific neuroscience antibodies and assays market generated a revenue of USD 709.5 million in 2024.
- The market is expected to grow at a CAGR of 6.4% from 2025 to 2033.
- In terms of segment, consumables was the largest revenue generating product in 2024.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2024 | USD 709.5 million |
| Market revenue in 2033 | USD 1,212.7 million |
| Growth rate | 6.4% (CAGR from 2025 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.1% of the global neuroscience antibodies and assays market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,212.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neuroscience Antibodies and Assays Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Santa Cruz Biotechnology Inc. | View profile | - | - | - |
| Exalenz Bioscience | View profile | 11-50 | Union, New Jersey, United States, North America | http://www.exalenz.com/ |
| Rockland Immunochemicals | View profile | 101-250 | Royersford, Pennsylvania, United States, North America | https://www.rockland.com |
| GenScript | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Bio-Rad Laboratories, Inc. | View profile | - | - | - |
| Cell Signaling Technology | View profile | 501-1000 | Danvers, Massachusetts, United States, North America | https://www.cellsignal.com |
| Abcam PLC | View profile | 1760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | https://www.abcam.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Asia Pacific neuroscience antibodies and assays market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neuroscience antibodies and assays market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 104.38% in 2024. Horizon Databook has segmented the Asia Pacific neuroscience antibodies and assays market based on consumables covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Asia Pacific neuroscience antibodies and assays market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific neuroscience antibodies and assays market databook
-
Our clientele includes a mix of neuroscience antibodies and assays market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific neuroscience antibodies and assays market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific neuroscience antibodies and assays market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
